Baird Medical Investment Holdings (BDMD) Total Non-Current Liabilities (2023 - 2026)
Baird Medical Investment Holdings' (BDMD) quarterly Total Non-Current Liabilities came in at $4.3 million in Q2 2026, down 26.73% year-over-year from $5.9 million in Q2 2025, and down 29.31% quarter-over-quarter from $6.1 million in Q4 2025.
Analysis
Baird Medical Investment Holdings (BDMD) Total Non-Current Liabilities (2023 - 2026) Analysis & Trends
Baird Medical Investment Holdings (BDMD) has reported Total Non-Current Liabilities for 4 consecutive years, with $4.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Non-Current Liabilities fell 26.73% year-over-year to $4.3 million in Q2 2026; TTM through Jun 2026 was $4.3 million, a 26.73% decrease from a year earlier, with the FY2025 full-year figure at $6.1 million, up 70.82% from the prior year.
- Total Non-Current Liabilities was $4.3 million for Q2 2026 at Baird Medical Investment Holdings, down from $6.1 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $6.1 million in Q4 2025 and troughed at $2.0 million in Q4 2023.
- A 4-year average of $4.4 million and a median of $4.3 million in 2026 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities soared 76.69% in 2024 and slipped 26.73% in 2026, its largest moves.
- Over 4 years, Total Non-Current Liabilities stood at $2.0 million in 2023, then soared by 76.69% to $3.6 million in 2024, then jumped by 70.82% to $6.1 million in 2025, then fell by 29.31% to $4.3 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $4.3 million (Q2 2026), $6.1 million (Q4 2025), and $5.9 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Baird Medical Investment Holdings | 29.74 Mn | 29.45 Mn | - | 4.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.32 Mn |
| Dec 31, 2025 | 6.11 Mn |
| Jun 30, 2025 | 5.90 Mn |
| Dec 31, 2024 | 3.58 Mn |
| Dec 31, 2023 | 2.03 Mn |